KYNTRA BIO, INC. Available-for-sale Securities, Equity Securities
KYNTRA BIO, INC. (KYNB) had Available-for-sale Securities, Equity Securities of $244.00 thousand as of 2020-12-31, per its 10-K filed 2021-03-01.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecuritiesEquitySecurities · last filed 2021-03-01
- 2020-12-31: Available-for-sale Securities, Equity Securities $244.00K.
- 2019-12-31: Available-for-sale Securities, Equity Securities $255.00K.
- 2018-12-31: Available-for-sale Securities, Equity Securities $234.00K.
- 2017-12-31: Available-for-sale Securities, Equity Securities $221.00K.
| Period end | Available-for-sale Securities, Equity Securities |
|---|---|
| 2020-12-31 | $244.00K 10-K · filed 2021-03-01 |
| 2019-12-31 | $255.00K 10-K · filed 2020-03-02 |
| 2018-12-31 | $234.00K 10-K · filed 2019-02-27 |
| 2017-12-31 | $221.00K 10-K · filed 2018-02-27 |
| 2016-12-31 | $225.00K 10-K · filed 2017-03-01 |
| 2015-12-31 | $197.00K 10-K · filed 2016-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 |